Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Continuous Infusion + Chemotherapy in Advanced NSCLC
NCT03123445Phase 2Unknown
- Sponsor
- China Medical University
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by China Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03123445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03123445.